Published in Tidsskr Nor Laegeforen on April 30, 1999
Fatal overdose with citalopram. Lancet (1996) 3.91
Association of venous thromboembolism and clozapine. Lancet (2000) 3.52
Effects of ibuprofen, diclofenac, naproxen, and piroxicam on the course of pregnancy and pregnancy outcome: a prospective cohort study. BJOG (2013) 1.58
Digitoxin medication and cancer; case control and internal dose-response studies. BMC Cancer (2001) 1.50
[The transfer of selective serotonin reuptake inhibitors to human milk]. Tidsskr Nor Laegeforen (2001) 1.44
Medication use in pregnancy: a cross-sectional, multinational web-based study. BMJ Open (2014) 1.41
Characterisation of zuclopenthixol metabolism by in vitro and therapeutic drug monitoring studies. Acta Psychiatr Scand (2010) 1.41
[Selective serotonin uptake inhibitors--are severe adverse effects a problem?]. Tidsskr Nor Laegeforen (2001) 1.39
[New intoxicants--new diagnostic challenges]. Tidsskr Nor Laegeforen (1998) 1.39
[Depression caused by beta blockaders. Unknown mechanisms behind well-known adverse effects]. Lakartidningen (1995) 1.38
Peripheral neurologic deficits in relation to subarachnoid or epidural administration of local anesthetics for surgery. A survey of 21 cases. Acta Anaesthesiol Scand (1997) 1.35
Gender differences in drug effects: implications for anesthesiologists. Acta Anaesthesiol Scand (2003) 1.13
Prevalence of diabetes and impaired glucose tolerance in patients treated with clozapine compared with patients treated with conventional depot neuroleptic medications. J Clin Psychiatry (1998) 1.10
Myocarditis related to clozapine treatment. J Clin Psychopharmacol (2001) 1.04
Influence of gender and oral contraceptives on CYP2D6 and CYP2C19 activity in healthy volunteers. Br J Clin Pharmacol (2001) 0.92
Chemotypes of Fusobacterium nucleatum lipopolysaccharides. Acta Pathol Microbiol Scand B (1978) 0.92
Oral symptoms in bulimia nervosa. A survey of 34 cases. Acta Odontol Scand (1991) 0.86
Effects of comedication on the serum levels of aripiprazole: evidence from a routine therapeutic drug monitoring service. Pharmacopsychiatry (2007) 0.86
Paroxetine level in breast milk. J Clin Psychiatry (1996) 0.85
Maternal characteristics and migraine pharmacotherapy during pregnancy: cross-sectional analysis of data from a large cohort study. Cephalalgia (2009) 0.85
Peripheral sensory disturbances related to treatment with fluoroquinolones. J Antimicrob Chemother (1996) 0.84
Excretion of paroxetine into breast milk. J Clin Psychiatry (1999) 0.83
Immunochemical studies of partially hydrolyzed lipopolysaccharide from Fusobacterium nucleatum Fev1. Eur J Biochem (1979) 0.83
Reduced effect of warfarin caused by ubidecarenone. Lancet (1994) 0.82
Pharmacokinetics of progesterone and its metabolites allopregnanolone and pregnanolone after oral administration of low-dose progesterone. Maturitas (2006) 0.80
Absence of interaction between erythromycin and a single dose of clozapine. Eur J Clin Pharmacol (1999) 0.80
Ventricular fibrillation related to reversal of the neuromuscular blockade in a patient with long QT syndrome. Acta Anaesthesiol Scand (1999) 0.80
Pharmacokinetics of intraperitoneally instilled aminophylline, terbutaline and tobramycin in pigs. Acta Anaesthesiol Scand (2007) 0.80
Serotonin syndrome induced by fluvoxamine-lithium interaction. Pharmacopsychiatry (1993) 0.79
Studies on carcinoembryonic and related antigens in malignant tumours of colon-rectum. Acta Pathol Microbiol Scand B Microbiol Immunol (1972) 0.78
[The role of serotonin in normal appetite regulation and in the pathogenesis of anorexia/bulimia]. Nord Med (1990) 0.78
A case of fluvoxamine intoxication demonstrating nonlinear elimination pharmacokinetics. J Clin Psychopharmacol (1996) 0.77
Fluvoxamine is a potent inhibitor of tacrine metabolism in vivo. Eur J Clin Pharmacol (1999) 0.77
Olanzapine disposition in humans is unrelated to CYP1A2 and CYP2D6 phenotypes. Eur J Clin Pharmacol (2001) 0.77
Lack of influence of menstrual cycle and premenstrual syndrome diagnosis on pregnanolone pharmacokinetics. Eur J Clin Pharmacol (1999) 0.76
Binding of [3H]paroxetine to serotonin uptake sites and of [3H]lysergic acid diethylamide to 5-HT2A receptors in platelets from women with premenstrual dysphoric disorder during gonadotropin releasing hormone treatment. Psychoneuroendocrinology (2001) 0.76
Anticonvulsant use during lactation. Drug Saf (2000) 0.76
Influence of postmenopausal hormone replacement therapy on platelet serotonin uptake site and serotonin 2A receptor binding. Obstet Gynecol (2001) 0.76
Hyponatremia during treatment with clomipramine, perphenazine, or clozapine: study of therapeutic drug monitoring samples. J Clin Psychopharmacol (1996) 0.76
[Antidepressive agents and breast feeding]. Tidsskr Nor Laegeforen (1998) 0.75
Medicine Cabinet: Drug treatment of depression. West J Med (1999) 0.75
Platelet [3H]paroxetine and [3H]lysergic acid diethylamide binding in seasonal affective disorder and the effect of bright light therapy. Biol Psychiatry (1999) 0.75
[Folic acid deficiency, cancer and congenital abnormalities]. Tidsskr Nor Laegeforen (1996) 0.75
Helicopter emergency medical service. Lancet (1996) 0.75
Effect of caffeine on clozapine pharmacokinetics in healthy volunteers. Br J Clin Pharmacol (2000) 0.75
Impact of improved treatment of sexually transmitted disease on HIV infection. Lancet (1995) 0.75
Death resulting from asthma associated with sertraline "overdose". Am J Forensic Med Pathol (2001) 0.75
Risperidone metabolism and the impact of being a cytochrome P450 2D6 ultrarapid metabolizer. J Clin Psychiatry (2000) 0.75
Prolonged sedation and slowly decreasing clozapine serum concentrations after an overdose. J Clin Psychopharmacol (1999) 0.75
Are adverse drug reactions attributed to fluvoxamine caused by concomitant intake of caffeine? Eur J Clin Pharmacol (1998) 0.75
Evaluation of benefits of drug analysis in the routine clinical management of acute self poisoning. J Toxicol Clin Toxicol (1984) 0.75
Oral intake of a toluene-containing thinner. Effects and headspace gas chromatographic analytical diagnosis. Arch Toxicol Suppl (1985) 0.75
Low serum sodium concentrations during treatment with citalopram in elderly patients: relationship to serum citalopram levels and to platelet serotonin 5-HT2A receptor status. J Clin Psychopharmacol (2000) 0.75
[Acutely self-poisoned patients in Trondheim 1978. A prospective study--clinical and pharmacological aspects]. Tidsskr Nor Laegeforen (1984) 0.75
[Use of carisoprodol (Somadril)]. Tidsskr Nor Laegeforen (1997) 0.75
Association between aortic aneurysm rupture and short-term prednisolone use in two patients with dermatological disorders. J Eur Acad Dermatol Venereol (2008) 0.75
[Somatic and biochemical complications in bulimia]. Tidsskr Nor Laegeforen (1990) 0.75
Carbamazepine interference in a high-performance liquid chromatography analysis for perphenazine. Ther Drug Monit (1994) 0.75
[Experiences and strategies of AIDS preventive work in Mudzi and Mutoko. Experiences from 2 rural districts in Zimbabwe]. Tidsskr Nor Laegeforen (1994) 0.75
Case report of successful treatment of bulimia nervosa with fluvoxamine. Pharmacopsychiatry (1991) 0.75
[Bulimia. A review of the literature]. Tidsskr Nor Laegeforen (1986) 0.75
[Occurrence of urinary incontinence. A literature review with special attention to factors which contribute to differences in occurrence]. Tidsskr Nor Laegeforen (1989) 0.75
[One year's written drug information to a general practitioner]. Tidsskr Nor Laegeforen (2001) 0.75
[Hypertension and heart failure caused by NSAID preparations. Significant adverse effects?]. Tidsskr Nor Laegeforen (2000) 0.75
[Combination therapy with antidepressive agents--risks for interactions]. Tidsskr Nor Laegeforen (1993) 0.75
[Drugs in practice]. Tidsskr Nor Laegeforen (2000) 0.75
[Treatment of serious allergic reactions]. Tidsskr Nor Laegeforen (2002) 0.75
Increased glucose intolerance related to digoxin treatment in patients with type 2 diabetes mellitus. J Intern Med (1999) 0.75
[Urinary incontinence. A study of occurrence in the municipality of Sund]. Tidsskr Nor Laegeforen (1989) 0.75
[Long QT interval as adverse effect--risk of fatal arrhythmias]. Tidsskr Nor Laegeforen (2000) 0.75
Urinary excretion of codeine, ethylmorphine, and their metabolites: relation to the CYP2D6 activity. Ther Drug Monit (1997) 0.75
[Nutmeg--more than a spice]. Tidsskr Nor Laegeforen (1998) 0.75
[A regional center for reporting adverse drug reactions in Umeå. Prompt handling results in quick feedback]. Lakartidningen (1995) 0.75
[3H]GBR 12935 binding in platelets from poor and extensive cytochrome P-4502D6 metabolizers. Eur J Pharmacol (1999) 0.75
[Use of paracetamol in adults]. Tidsskr Nor Laegeforen (2000) 0.75
[Carcinoembryonic antigens (CES) in malignant tumors of the colon and rectum]. Tidsskr Nor Laegeforen (1972) 0.75
[Acute self poisoning. Use and benefits of the determination of serum concentrations of drugs and poisons as an immediate help]. Tidsskr Nor Laegeforen (1986) 0.75
Self-poisoning with theophylline. The effect of repeated doses oral charcoal on drug elimination. Acta Med Scand (1986) 0.75
[Use of paracetamol to children]. Tidsskr Nor Laegeforen (2001) 0.75
[Forced alkalic diuresis. How forced should the forced alkalic diuresis be?]. Tidsskr Nor Laegeforen (1989) 0.75
[Organophosphate poisoning]. Tidsskr Nor Laegeforen (1990) 0.75
Transfer of carisoprodol to breast milk. Ther Drug Monit (2001) 0.75
[NSAID preparations for external application--do they have any effect and should they be used?]. Tidsskr Nor Laegeforen (2001) 0.75
[Detection of narcotic drugs in the urine. A 2-year case material from Health Region IV]. Tidsskr Nor Laegeforen (1984) 0.75
[Drug-induced rhinitis--significant adverse effect]. Tidsskr Nor Laegeforen (2001) 0.75
[Bulimia and destruction of dental hard tissues]. Nor Tannlaegeforen Tid (1987) 0.75
Binding of [(3)H]lysergic acid diethylamide to serotonin 5-HT(2A) receptors and of [(3)H]paroxetine to serotonin uptake sites in platelets from healthy children, adolescents and adults. Neuropsychobiology (1999) 0.75